 81%; SMA, 19%). They reported that
73% of the patients had sustained relief of their symptoms and that the favorable results were not related to
the location of the lesion (ie, CA vs SMA).
Because the natural history of patients with asymptomatic MAOD remains poorly deﬁned, it is no surprise that
the indications for prophylactic revascularization remain
unresolved. Justiﬁcation for revascularization in this
setting is provided by the